Momenta Wins Dismissal Of Blood-Clot Drug Antitrust Suit
A Massachusetts federal judge on Wednesday said that Amphastar Pharmaceuticals Inc. cannot bring federal antitrust claims against Momenta Pharmaceuticals Inc. for allegedly suppressing competition of sales of a generic blood clot...To view the full article, register now.
Already a subscriber? Click here to view full article